Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Surveillance should be confined to the surgically fit
| The first 150 words of the full text of this article appear below. |
In 1950 Barrett wrote a treatise to clarify confusion over oesophagitis which "connote[s] one thing to some people and something quite different to others."1 He described gastric mucosa extending into the tubular oesophagus as the result of a congenitally shortened oesophagus. The presence of columnar lined epithelium in the oesophagus is now referred to as Barrett's oesophagus. It is associated with chronic gastro-oesophageal reflux disease and an increased risk of oesophageal adenocarcinoma.2 Quantifying this risk, and the best methods for early diagnosis, are still the subjects of considerable debate.
Endoscopically the distal end of the pearly white oesophagus is readily
distinguished from the salmon red of the proximal stomach: the so
called "Z line" or squamocolumnar junction. However, the location
of the Z line may be difficult to identify in cases of intense
inflammation, hiatal hernia, and stricture patients with oesophagitis.
Extension of the Z line proximally
representing columnar replacement
of
Read all Rapid Responses